JP2015516452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516452A5 JP2015516452A5 JP2015511958A JP2015511958A JP2015516452A5 JP 2015516452 A5 JP2015516452 A5 JP 2015516452A5 JP 2015511958 A JP2015511958 A JP 2015511958A JP 2015511958 A JP2015511958 A JP 2015511958A JP 2015516452 A5 JP2015516452 A5 JP 2015516452A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- weeks
- refers
- treated
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002193 Pain Diseases 0.000 description 6
- 208000005298 acute pain Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000002831 pharmacologic agent Substances 0.000 description 2
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003898 | 2012-05-18 | ||
| EP12003898.9 | 2012-05-18 | ||
| EP13159330 | 2013-03-15 | ||
| EP13159330.3 | 2013-03-15 | ||
| PCT/EP2013/001471 WO2013170972A1 (en) | 2012-05-18 | 2013-05-16 | Pharmaceutical composition comprising (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and an anticonvulsant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015516452A JP2015516452A (ja) | 2015-06-11 |
| JP2015516452A5 true JP2015516452A5 (enExample) | 2017-03-09 |
| JP6116679B2 JP6116679B2 (ja) | 2017-04-19 |
Family
ID=48446244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511958A Active JP6116679B2 (ja) | 2012-05-18 | 2013-05-16 | （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミンおよび抗けいれん剤を含む医薬組成物 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9345689B2 (enExample) |
| EP (1) | EP2852384B1 (enExample) |
| JP (1) | JP6116679B2 (enExample) |
| CN (1) | CN104284656A (enExample) |
| AU (1) | AU2013262078B2 (enExample) |
| CA (1) | CA2873871A1 (enExample) |
| CY (1) | CY1118634T1 (enExample) |
| DK (1) | DK2852384T3 (enExample) |
| EA (1) | EA029767B1 (enExample) |
| ES (1) | ES2624220T3 (enExample) |
| HR (1) | HRP20170517T1 (enExample) |
| HU (1) | HUE031984T2 (enExample) |
| IL (1) | IL235654A (enExample) |
| LT (1) | LT2852384T (enExample) |
| MX (1) | MX353177B (enExample) |
| PL (1) | PL2852384T3 (enExample) |
| PT (1) | PT2852384T (enExample) |
| RS (1) | RS55905B1 (enExample) |
| SI (1) | SI2852384T1 (enExample) |
| WO (1) | WO2013170972A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10022353B2 (en) | 2015-01-23 | 2018-07-17 | Grünenthal GmbH | Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function |
| EP3419621A4 (en) * | 2016-02-26 | 2019-10-30 | The Johns Hopkins University | PHARMACOLOGICAL MODULATORS OF NAV1.1 VOLTAGE-CONTROLLED SODIUM CHANNELS ASSOCIATED WITH MECHANICAL PAIN |
| WO2017195144A1 (en) * | 2016-05-12 | 2017-11-16 | Jubilant Generics Limited | Pharmaceutical compositions comprising brivaracetam |
| JP7264813B2 (ja) * | 2016-12-06 | 2023-04-25 | トピカル・イノベーションズ・ベー・フェー | 末梢神経障害性疼痛の治療に使用するための局所作用用フェニトイン |
| EP3826610A4 (en) * | 2018-07-24 | 2022-05-04 | Zenvision Pharma LLP | Nasal drug delivery system of brivaracetam or salt thereof |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4783337A (en) | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4612008A (en) | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
| US5708035A (en) | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
| US5472711A (en) | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| US5330761A (en) | 1993-01-29 | 1994-07-19 | Edward Mendell Co. Inc. | Bioadhesive tablet for non-systemic use products |
| US5455046A (en) | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5399362A (en) | 1994-04-25 | 1995-03-21 | Edward Mendell Co., Inc. | Once-a-day metoprolol oral dosage form |
| US20030056896A1 (en) * | 1995-05-12 | 2003-03-27 | Frank Jao | Effective therapy for epilepsies |
| US6117900A (en) | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| US8288372B2 (en) | 2002-11-26 | 2012-10-16 | Alexza Pharmaceuticals, Inc. | Method for treating headache with loxapine |
| US20040222123A1 (en) * | 2003-05-06 | 2004-11-11 | Barr Laboratories, Inc. | Kit for pharmaceuticals |
| CN1245379C (zh) | 2003-10-30 | 2006-03-15 | 曹桂东 | 加巴喷丁的制法 |
| DE10360792A1 (de) | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| GB0412878D0 (en) | 2004-06-09 | 2004-07-14 | Pfizer Ltd | Use |
| US20080261984A1 (en) | 2004-06-09 | 2008-10-23 | Pfizer Inc. | Use of S,S-Reboxetine in the Treatment of Pain |
| US8093408B2 (en) | 2005-06-21 | 2012-01-10 | The Company Wockhardt | Antidepressant oral pharmaceutical compositions |
| US20080014271A1 (en) | 2006-07-13 | 2008-01-17 | Ucb, S.A. | Novel pharmaceutical compositions comprising levetiracetam |
| DE102006046745A1 (de) | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| JP2008106028A (ja) * | 2006-10-26 | 2008-05-08 | Boehringer Ingelheim Internatl Gmbh | 慢性疼痛の治療におけるフリバンセリンの使用 |
| US20080153874A1 (en) | 2006-12-22 | 2008-06-26 | Allergan Inc. | Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| WO2008108639A1 (en) | 2007-03-08 | 2008-09-12 | Avantium Holding B.V. | Co-crystalline forms of carbamazepine |
| EP1977744A1 (en) | 2007-04-03 | 2008-10-08 | Chemo Ibérica, S.A. | Polymorphic Form alpha of (S)-Pregabalin and process for its preparation |
| CA2710318A1 (en) * | 2007-12-21 | 2009-07-09 | Paz Arzneimittel-Entwicklungsgesellscaft Mbh | Drugs as well as their production and use in the treatment of pain-associated neuropathies |
| US20090298947A1 (en) | 2008-05-28 | 2009-12-03 | Pliva Hrvatska D.O.O. | Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| SI2331210T1 (sl) * | 2008-09-05 | 2014-10-30 | Gruenenthal Gmbh | Farmacevtska kombinacija 3-(3-dimetilamino-1-etil-2-metil-propil)-fenola in antiepileptika |
| DE102009013613A1 (de) | 2009-03-17 | 2010-09-23 | Ratiopharm Gmbh | Trockenverarbeitung von Retigabin |
| EP2600850B1 (en) * | 2010-08-04 | 2018-10-17 | Grünenthal GmbH | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain |
| PL2600838T3 (pl) * | 2010-08-04 | 2016-02-29 | Gruenenthal Gmbh | Farmaceutyczna postać dawkowania zawierająca 6'-fluoro-(N-metylo- lub N,N-dimetylo)-4-fenylo-4'9'-dihydro-3'H-spiro[cykloheksano-1,1'-pirano[3,4b]indolo]-4-aminę |
| JP6010534B2 (ja) * | 2010-08-04 | 2016-10-19 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ６’−フルオロ−（Ｎ−メチル−又はＮ，Ｎ−ジメチル−）−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミンを含む医薬剤形 |
-
2013
- 2013-05-13 US US13/892,751 patent/US9345689B2/en not_active Expired - Fee Related
- 2013-05-16 RS RS20170381A patent/RS55905B1/sr unknown
- 2013-05-16 WO PCT/EP2013/001471 patent/WO2013170972A1/en not_active Ceased
- 2013-05-16 SI SI201330569A patent/SI2852384T1/sl unknown
- 2013-05-16 EA EA201401271A patent/EA029767B1/ru not_active IP Right Cessation
- 2013-05-16 PT PT137230041T patent/PT2852384T/pt unknown
- 2013-05-16 MX MX2014013179A patent/MX353177B/es active IP Right Grant
- 2013-05-16 ES ES13723004.1T patent/ES2624220T3/es active Active
- 2013-05-16 HU HUE13723004A patent/HUE031984T2/en unknown
- 2013-05-16 PL PL13723004T patent/PL2852384T3/pl unknown
- 2013-05-16 CA CA2873871A patent/CA2873871A1/en not_active Abandoned
- 2013-05-16 AU AU2013262078A patent/AU2013262078B2/en not_active Ceased
- 2013-05-16 CN CN201380025637.XA patent/CN104284656A/zh active Pending
- 2013-05-16 HR HRP20170517TT patent/HRP20170517T1/hr unknown
- 2013-05-16 LT LTEP13723004.1T patent/LT2852384T/lt unknown
- 2013-05-16 JP JP2015511958A patent/JP6116679B2/ja active Active
- 2013-05-16 EP EP13723004.1A patent/EP2852384B1/en not_active Not-in-force
- 2013-05-16 DK DK13723004.1T patent/DK2852384T3/en active
-
2014
- 2014-11-12 IL IL235654A patent/IL235654A/en active IP Right Grant
-
2017
- 2017-02-15 CY CY20171100205T patent/CY1118634T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| HRP20200600T1 (hr) | Tapentadol za sprječavanje i liječenje depresije i tjeskobe | |
| JP2016518337A5 (enExample) | ||
| BR112013032122A2 (pt) | liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos | |
| MX2017010287A (es) | Composiciones farmaceuticas que comprenden n-(3,5-dimetoxifenil)-n '-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il)quinoxalin-6-il]eta no-1,2-diamina. | |
| JP2016053040A5 (enExample) | ||
| MX383665B (es) | Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer. | |
| JP2015523407A5 (enExample) | ||
| JP2015057451A5 (enExample) | ||
| JP2015516452A5 (enExample) | ||
| JP2016512817A5 (enExample) | ||
| HRP20241716T1 (hr) | Postupci liječenja promjena u ponašanju | |
| CN110062628A (zh) | 一种瑞卡帕布口服缓控释药物组合物及其用途 | |
| BR112015029894A2 (pt) | forma de dosagem farmacêutica sólida | |
| JP2015516450A5 (enExample) | ||
| UA118474C2 (uk) | (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| JP2017513944A5 (enExample) | ||
| JP2015516449A5 (enExample) | ||
| UY31790A (es) | Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona | |
| BR112014004737A2 (pt) | composto de composição de cloridrato de ambroxol e método de preparação do composto | |
| JP2015516451A5 (enExample) | ||
| CL2016000182A1 (es) | Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación | |
| ECSP15025868A (es) | Composición que comprende un extracto purificado aíslado de pseudolysimachion rotundum var. subintegrum que contiene una cantidad abundante de ingrediente activo o los compuestos aislados del mismo, como un ingrediente activo para prevenir/tratar la enfermedad pulmonar obstructiva crónica, y su uso | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| HUE066609T2 (hu) | Adagolási forma betegség kezelésében vagy megelõzésében történõ alkalmazásra |